10-Q Filing

PFIZER INC CIK: 78003 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0000078003-22-000101`
Period End Date	20220930
Filing Date	20221109
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	pfe-20221002_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 92 Cash Flow Statement 94 Stockholders Equity 44 Comprehensive Income 68

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$474.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$492.00M	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$14.93B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.94B	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.07B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.30B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$34.83B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.57B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.64B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$29.12B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2022$474; 2021$492	`AccountsReceivableNetCurrent`	$16.08B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2022$474; 2021$492	`AccountsReceivableNetCurrent`	$11.48B	USD	Point-in-time
Inventories	`InventoryNet`	$9.51B	USD	Point-in-time
Inventories	`InventoryNet`	$9.06B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$4.27B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$2.54B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.82B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$6.15B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$59.69B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$70.40B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$16.47B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$9.83B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$5.05B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$4.06B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2022$14,931; 2021$15,074	`PropertyPlantAndEquipmentNet`	$14.88B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2022$14,931; 2021$15,074	`PropertyPlantAndEquipmentNet`	$15.44B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$25.15B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$28.15B	USD	Point-in-time
Goodwill	`Goodwill`	$49.21B	USD	Point-in-time
Goodwill	`Goodwill`	$49.44B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$7.14B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$3.34B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$10.89B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$7.68B	USD	Point-in-time
Total assets	`Assets`	$195.35B	USD	Point-in-time
Total assets	`Assets`	$181.48B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2022$2,566; 2021$1,636	`DebtCurrent`	$4.04B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2022$2,566; 2021$1,636	`DebtCurrent`	$2.24B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$6.27B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$5.58B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.25B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.25B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.27B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$3.07B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$3.33B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$2.85B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$3.07B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$6.19B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$24.94B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$19.65B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$42.67B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$44.31B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$32.63B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$36.20B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$2.74B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$3.49B	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$235.00M	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$222.00M	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$616.00M	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$349.00M	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$9.70B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$11.33B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$12.24B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$9.74B	USD	Point-in-time
Total liabilities	`Liabilities`	$102.46B	USD	Point-in-time
Total liabilities	`Liabilities`	$104.01B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$473.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$476.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$90.59B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$91.36B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$113.94B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$111.36B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$103.39B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$122.97B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.90B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.22B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$92.63B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$77.20B	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$262.00M	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$259.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.89B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.97B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.47B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$181.48B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$195.35B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$76.04B	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$22.64B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$57.45B	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$24.04B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$24.70B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$9.93B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$6.06B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$21.09B	USD	3 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.39B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$8.60B	USD	3 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.90B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$9.03B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.68B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.91B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$7.81B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.70B	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$762.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$524.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$1.00B	USD	3 Qtrs
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$880.00M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$822.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$2.48B	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$2.74B	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$968.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$646.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$580.00M	USD	3 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$667.00M	USD	3 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$199.00M	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-1.06B	USD	3 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$4.04B	USD	3 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$59.00M	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$1.70B	USD	1 Quarter
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$20.48B	USD	3 Qtrs
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.84B	USD	1 Quarter
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.00B	USD	1 Quarter
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$29.50B	USD	3 Qtrs
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$3.10B	USD	3 Qtrs
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$1.60B	USD	3 Qtrs
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$-328.00M	USD	1 Quarter
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$356.00M	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$26.40B	USD	3 Qtrs
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.64B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$18.88B	USD	3 Qtrs
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.17B	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-13.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-248.00M	USD	3 Qtrs
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$4.00M	USD	3 Qtrs
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-21.00M	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.16B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.62B	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$12.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$15.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$47.00M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$27.00M	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$8.15B	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$8.61B	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$18.59B	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$26.38B	USD	3 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$3.37	USD	3 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.54	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.45	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$4.70	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.04	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$4.71	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$3.32	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.54	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.45	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.51	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.43	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$3.31	USD	3 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$4.60	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.04	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$3.27	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.51	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.42	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$4.60	USD	3 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.60B	shares	3 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.61B	shares	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.61B	shares	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.61B	shares	3 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.72B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.69B	shares	3 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.73B	shares	3 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.72B	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.16B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.62B	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-21.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$4.00M	USD	3 Qtrs
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-248.00M	USD	3 Qtrs
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-13.00M	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.17B	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$26.40B	USD	3 Qtrs
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.64B	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$18.88B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$3.54B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$3.86B	USD	3 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$287.00M	USD	3 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$93.00M	USD	3 Qtrs
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$-3.61B	USD	3 Qtrs
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$-3.40B	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$686.00M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$508.00M	USD	3 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$1.93B	USD	3 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$532.00M	USD	3 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$1.85B	USD	3 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$-1.48B	USD	3 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$7.61B	USD	3 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$-10.87B	USD	3 Qtrs
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$26.99B	USD	3 Qtrs
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$20.68B	USD	3 Qtrs
Net cash provided by/(used in) operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-327.00M	USD	3 Qtrs
Net cash provided by/(used in) operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$26.67B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$20.68B	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.71B	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.23B	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$26.28B	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$29.70B	USD	3 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$15.85B	USD	3 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$35.09B	USD	3 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$10.88B	USD	3 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$7.15B	USD	3 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$861.00M	USD	3 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$1.63B	USD	3 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$569.00M	USD	3 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$446.00M	USD	3 Qtrs
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.22B	USD	3 Qtrs
Dividends received from Haleon/GSK Consumer Healthcare JV (Note 2C)	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	3 Qtrs
Dividends received from Haleon/GSK Consumer Healthcare JV (Note 2C)	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$3.96B	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$370.00M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$200.00M	USD	3 Qtrs
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-11.37B	USD	3 Qtrs
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-19.95B	USD	3 Qtrs
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-8.00M	USD	3 Qtrs
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.37B	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.96B	USD	3 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	-	USD	3 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$3.89B	USD	3 Qtrs
Payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$1.00M	USD	3 Qtrs
Payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$3.89B	USD	3 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$870.00M	USD	3 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$265.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$997.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$1.61B	USD	3 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$1.00B	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$6.74B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$6.54B	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-185.00M	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-342.00M	USD	3 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.46B	USD	3 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.82B	USD	3 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-32.00M	USD	3 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-139.00M	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-646.00M	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$209.00M	USD	3 Qtrs
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.34B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.03B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.03B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.34B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$2.94B	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	$4.92B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.21B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.12B	USD	3 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$28.00M	USD	3 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$-26.00M	USD	3 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.55B	USD	3 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$463.00M	USD	3 Qtrs

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.20	USD	3 Qtrs
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.39	USD	1 Quarter
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.40	USD	1 Quarter
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.17	USD	3 Qtrs
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.97B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.47B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.89B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Net income	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income	`ProfitLoss`	$8.16B	USD	1 Quarter
Net income	`ProfitLoss`	$8.62B	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-1.11B	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.34B	USD	3 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-338.00M	USD	3 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-894.00M	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$6.73B	USD	3 Qtrs
Common stock	`DividendsCommonStockCash`	$2.25B	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$6.57B	USD	3 Qtrs
Common stock	`DividendsCommonStockCash`	$2.19B	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$8.00M	USD	3 Qtrs
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$7.00M	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$8.00M	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$7.00M	USD	3 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$855.00M	USD	3 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$108.00M	USD	3 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$161.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$634.00M	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$2.00B	USD	3 Qtrs
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	$79.00M	USD	3 Qtrs
Other	`StockholdersEquityOther`	$46.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$4.00M	USD	3 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.89B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.97B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.47B	USD	Point-in-time

Comprehensive Income 68 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.16B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.62B	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-366.00M	USD	3 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-918.00M	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-2.55B	USD	3 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-866.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$589.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$213.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$179.00M	USD	3 Qtrs
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$1.44B	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$615.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-286.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-48.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$972.00M	USD	3 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$261.00M	USD	1 Quarter
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$464.00M	USD	3 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$471.00M	USD	3 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-26.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-777.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.40B	USD	3 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-266.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-128.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-1.09B	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$172.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-9.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-606.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-171.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-303.00M	USD	3 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-257.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-300.00M	USD	3 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-99.00M	USD	3 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-31.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-119.00M	USD	3 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-39.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-58.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$2.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-62.00M	USD	3 Qtrs
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-8.00M	USD	3 Qtrs
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$181.00M	USD	3 Qtrs
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$107.00M	USD	3 Qtrs
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$97.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$29.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-382.00M	USD	3 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-959.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-2.49B	USD	3 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-1.14B	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-149.00M	USD	3 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-65.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-44.00M	USD	3 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-33.00M	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-2.34B	USD	3 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-338.00M	USD	3 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-894.00M	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-1.11B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.26B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$24.07B	USD	3 Qtrs
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.51B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$18.30B	USD	3 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$16.00M	USD	3 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$48.00M	USD	3 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$9.00M	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$10.00M	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$24.05B	USD	3 Qtrs
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$7.26B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$7.50B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$18.25B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.